Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Evaluation and Analysis of Drug-Use in Hospitals of China》 2012-01
Add to Favorite Get Latest Update

Utilization of Lipid-regulating Agents in Shihezhi People's Hospital During 2008-2010

ZHANG Quan-lin*,GAO Ling,YAO Hai(Dept.of Pharmacy,Shihezhi People's Hospital,Xinjiang Shihezhi 832000,China)  
OBJECTIVE: To investigate the status quo and tendency of the utilization of lipid-regulating drugs in our hospital to provide reference for clinical rational use of blood lipid-lowering drugs.METHODS: By using DDD analysis,the use of blood lipid-lowering drugs during 2008-2010 in our hospital was analyzed statistically with regard to consumption sum,DDDs and DDC(defined daily cost).RESULTS: The consumption sum of blood lipid-lowering drugs increased year by year,with statins assuming a dominating place.With distinctive mechanism of action,probucol gained more and more clinical attention and its consumption witnessed a sharp increase.CONCLUSION: The utilization structure of blood lipid-lowering drugs in our hospital is basically stable and rational.Some blood lipid-lowering drugs show bright future in clinical use.
【CateGory Index】: R96
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Citations】
Chinese Journal Full-text Database 4 Hits
1 LI Ting-ting,GUO Yuan(Department of Cardiology,The Qilu Hospital of Shandong University,Jinan 250012,China);Advances and Prospects of Probucol[J];Advances in Cardiovascular Diseases;2009-04
2 SHA Ai-hui ,LI Li,LI Zhi-jun ( Dept. of Pharmacy,Beijing Tongren Hospital Affiliated to Capital Medical University,Beijing 100730,China);Utilization Review on Lipid Regulating Agents Used in Our Hospital from 2007 to 2009[J];Evaluation and Analysis of Drug-Use in Hospitals of China;2010-05
3 ZHANG Wei-wei*,HU Xin,FU De-xing(Dept.of Pharmacy,Beijing Hospital of Ministry of Health,Beijing 100730,China);Utilization Analysis of Lipid-regulating Drugs in the Outpatient Pharmacy During the Period of 2007-2009[J];Evaluation and Analysis of Drug-Use in Hospitals of China;2011-02
4 FU Rui,CHEN Ping(Dept.of Pharmacy,Hainan Provincial People's Hospital,Haikou 570311,China);Analysis on the Utilization of Blood Lipid-lowering Drugs in 2 Hospitals of Haikou from 2007 to 2009[J];China Pharmacy;2010-30
【Co-citations】
Chinese Journal Full-text Database 7 Hits
1 FAN Gaolu1 LIU Ling2 1.Department of Pharmacy,the Third People's Hospital of Luoyang,Luoyang 471002,China;2.Department of Pharmacology,Medical of Henan Science and Technology University,Luoyang 471003,China;Utilization of lipid-regulating agents in our hospital during 2008-2010[J];China Medicine and Pharmacy;2011-18
2 LI Ying,ZHU Yu-hong(Department of Neurology,the Second Affiliated Hospital of Kunming Medical College,Kunming 650000,China);Efficacy Observatiom on PAS Therapy for Carotid Atherosclerosis[J];Modern Diagnosis & Treatment;2010-03
3 ZHANG Wei-wei*,HU Xin,FU De-xing(Dept.of Pharmacy,Beijing Hospital of Ministry of Health,Beijing 100730,China);Utilization Analysis of Lipid-regulating Drugs in the Outpatient Pharmacy During the Period of 2007-2009[J];Evaluation and Analysis of Drug-Use in Hospitals of China;2011-02
4 DU Hai-yan,LIN Yang(Dept.of Pharmacy,Capital Medical University Affiliated Beijing Anzhen Hospital;Clinical Drug Trial Agency,Beijing 100029,China);Utilization of Lipid-regulating Agents During 2008-2010 Period[J];Evaluation and Analysis of Drug-Use in Hospitals of China;2011-05
5 DAI Fei1,LIN Shaole2,SU Deyu3,ZHANG Xinghua1 1.The Astyclinic Hospital of Yong'an,Fujian Province,Yong'an 366000,China;2.Sanming Institute for Drug Control,Fujian Province,Sanming 365000,China;3.The First Hospital of Sanming City,Fujian Province,Sanming 365000,China;Determination of Bezafibrate tablets by HPLC[J];China Modern Medicine;2011-12
6 MA Wei-hong1,LI Qi2,YANG Xiao-ling3,LIU Wei-ping1(1.Dept. of Gerontology,The Affiliated Hospital of Guilin Medical College,Guilin 541001,China;2.Office of Admission & Employment,Guilin Medical College,Guilin 541004,China;3.Guilin Qixing Community Health Service Center,Guilin 541004,China);Drug Use and Health Management Mode in Senile Patients with Chronic Diseases in Guilin Lidong Community[J];Evaluation and Analysis of Drug-Use in Hospitals of China;2011-08
7 REN Ning,TANG Hui-fang The First Affiliated Hospital of Nanhua University,Hengyang 421001,Hunan,China;Effects and mechanism of probucol on cardic function in patients with ischemic cardiomyopathy heart failure[J];Chinese Journal of Clinical Pharmacology and Therapeutics;2011-11
【Secondary Citations】
Chinese Journal Full-text Database 10 Hits
1 HAO Bing1,MENG Xiao-ping1,YANG Dong-hua2,WANG Li1,GUO Hao*(1.Department of Cardiology,Second Hospital,Jilin University,Changchun 130041,China;2.Laboratory of Animal,Second Hospital,Jilin University,Changchun 130041,China);Inhibitory effect of Probucol on expression of serum matrix metalloproteinase 2 in patients with coronary heart disease[J];Journal of Jilin University(Medicine Edition);2007-03
2 Chen Min,Zheng Xuan,Huang Xuhui.Department of Pharmacy,Fujian Provincial Hospital,Fuzhou 350001,China;Utilization of lipid regulating agents in our hospital during the period 2005-2008[J];Fujian Medical Journal;2009-03
3 CAO Jian,ZHU Bing-Po,FAN Li,LI Xiao-Ying,and ZENG Qiang (Department of Geriatric Cardiology,Chinese People's Libration Army General Hospital,Beijng 100853,China);The Anti-Oxidation and-Inflammation Function of Probucol in the Elderly Patients with Low Extremity Atherosclerosis Disease[J];Chinese Journal of Arteriosclerosis;2006-04
4 ZHAO Shui-Ping,WANG Xing,HONG Shao-Cai,and WU Zhi-Hong(Department of Cardiology,the Second Xiangya Hospital of Central South University,Changsha 410011,China);Effect of Probucol on Heme Oxygenase-1 in Rabbits with Atherosclerosis[J];Chinese Journal of Arteriosclerosis;2008-06
5 ZHANG Dongmei,FENG Bo. Departement of Endocrinology,East Hospital,Tongji University,Shanghai 200120,China;Efficacy and safety of acipimox in treatment of patients with type 2 diabetes and hyperlipidemia and its influence on glucose metabolism[J];Shanghai Medical Journal;2008-11
6 ZHANG Dong-wei,WANG Hai-chang.Depatment of Cardiology,Xijing Hospital,Fourth Military Medicine University,Xi'an 710032,China;Clinical evaluation of different types of lipid-lowering Medicine[J];Chinese Journal of Practical Internal Medicine;2009-01
7 ZOU Ying1,FENG Lin1,TAO Lin2,DAI Hui-zhen3 ( 1. The First Affiliated Hospital of Nanjing Medical University,Nanjing JIANGSU 210029,China; 2. Scientific and Technic Information Institute of Shanghai Municipal Food and Drug Administration,SHANGHAI 200233,China; 3. Research Institute for Medicine Information of Jiangsu Province,Nanjing JIANGSU 210004,China);Analysis on antilipemic agents used in 157 hospitals of 6 cities in Yangtze River valley in 2007[J];Chinese Journal of New Drugs and Clinical Remedies;2009-06
8 YANG Yun Bo, LIAO Duan Fang 1, XIE Zhi Zhong 1, HUANG Hong Lin 1 (Dept of Pharmacology, Institute of Pharmacy,Traditional Chinese Medical College,Changsha 410007);Probucol prevention against restenosis by regulating functional vascular remodeling after percutaneous transluminal angioplasty in rabbits[J];Chinese Pharmacological Bulletin;2003-04
9 Liu debao,Bu haifu,Gui binjie (Dept of Orthopaedics, The First Affiliated Hospital of Anhui Medical University, Hefei 230022);Experimental study on prevention of hormonally ischemic necrosis of femoral head in rabbits with combined use of Probucol and Aspirin[J];Acta Universitatis Medicinalis Anhui;2006-01
10 ;Adverse reactions to simvastatin and its prevention and treatment[J];Adverse Drug Reactions Journal;2006-02
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved